PD1 and PDL-1 expression during progression from myelodysplastic syndrome to acute myelogenous leukemia

摘要

The present disclosure relates to a method for diagnosing in a subject the progression from myelodysplastic syndrome (MDS) to acute myelogenous leukemia (AML). Also disclosed are methods of treating AML in a subject diagnosed by the disclosed methods.